Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituents

Simple item page
dc.contributor.authorViladomiu, Monicaen
dc.contributor.authorHontecillas, Raquelen
dc.contributor.authorLu, Pinyien
dc.contributor.authorBassaganya-Riera, Josepen
dc.date.accessioned2017-09-18T09:44:49Zen
dc.date.available2017-09-18T09:44:49Zen
dc.date.issued2013-04-30en
dc.date.updated2017-09-18T09:44:49Zen
dc.description.abstractPomegranate fruit presents strong anti-inflammatory, antioxidant, antiobesity, and antitumoral properties, thus leading to an increased popularity as a functional food and nutraceutical source since ancient times. It can be divided into three parts: seeds, peel, and juice, all of which seem to have medicinal benefits. Several studies investigate its bioactive components as a means to associate them with a specific beneficial effect and develop future products and therapeutic applications. Many beneficial effects are related to the presence of ellagic acid, ellagitannins (including punicalagins), punicic acid and other fatty acids, flavonoids, anthocyanidins, anthocyanins, estrogenic flavonols, and flavones, which seem to be its most therapeutically beneficial components. However, the synergistic action of the pomegranate constituents appears to be superior when compared to individual constituents. Promising results have been obtained for the treatment of certain diseases including obesity, insulin resistance, intestinal inflammation, and cancer. Although moderate consumption of pomegranate does not result in adverse effects, future studies are needed to assess safety and potential interactions with drugs that may alter the bioavailability of bioactive constituents of pomegranate as well as drugs. The aim of this review is to summarize the health effects and mechanisms of action of pomegranate extracts in chronic inflammatory diseases.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationMonica Viladomiu, Raquel Hontecillas, Pinyi Lu, and Josep Bassaganya-Riera, “Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituents,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 789764, 18 pages, 2013. doi:10.1155/2013/789764en
dc.identifier.doihttps://doi.org/10.1155/2013/789764en
dc.identifier.urihttp://hdl.handle.net/10919/78976en
dc.language.isoenen
dc.publisherHindawien
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.holderCopyright © 2013 Monica Viladomiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.titlePreventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituentsen
dc.title.serialEvidence-Based Complementary and Alternative Medicineen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 2 of 2
Name:
ECAM.2013.789764.xml
Size:
15.63 KB
Format:
Extensible Markup Language
Download
Thumbnail Image
Name:
ECAM.2013.789764.pdf
Size:
2.75 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Journal Articles, Hindawi Press
Scholarly Works, Biomedical Sciences and Pathobiology
Scholarly Works, Fralin Life Sciences Institute
Scholarly Works, Virginia-Maryland College of Veterinary Medicine